Summary
The global Female Sexual Dysfunction Treatment Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2019.
Among women, the most common sexual dysfunction is low or absent sexual desire. It's also called dysuria, or an absence of interest. The causes of sexual dysfunction can vary from simple mental illness to a variety of physical and psychological conditions. The most common cause is low libido, which can be treated by non-pharmacologic means, such as psychotherapy and counseling. Some women may have been affected by past sexual trauma. The global female sexual dysfunction treatment market focuses on six regions namely North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. The global female sexual dysfunction treatment market is expected to witness significant growth during the forecast period, owing to growing high adoption of sexual dysfunction treatment.
Market Drivers
Technological developments in treatment options are expected to drive growth of the global female sexual dysfunction treatment market during the forecast period. Key companies involved in the market are focused on launching advanced treatment options, in order to cater to unmet needs. For instance, in June 2019, AMAG Pharmaceuticals received the U.S. Food and Drug Administration (FDA) approval for Vylessi to treat hypoactive sexual desire disorder in premenopausal women. Therefore, such factors are expected to drive growth of the global female sexual dysfunction treatment market during the forecast period. Moreover, high adoption of sexual dysfunction treatment is expected to propel the global female sexual dysfunction treatment market growth over the forecast period.
Market Restraint
Low awareness regarding the treatment in some regions and social barriers are expected to hinder the global female sexual dysfunction treatment market growth over the forecast period.
Regional Insights
Among regions, North America is expected to witness significant growth in the global female sexual dysfunction treatment market during the forecast period. This is owing to technological advancements and robust research and development activities across the region. Moreover, Asia Pacific is expected to register a robust growth rate, owing to increasing prevalence of sexual dysfunction in emerging economies such as India and China.
Competitive Section
Key companies involved in the global female sexual dysfunction treatment market are AMAG Pharmaceuticals Inc., Duchesnay Inc., Emotional Brain BV, Novo Nordisk AS, and Sprout Pharmaceuticals Inc.
For instance, in March 2021, Dare Bioscience Inc. reported the initiation of Phase 2b Respond Study of Sildenafil Cream, 3.6% for the treatment of women with female sexual arousal disorder.
The Female Sexual Dysfunction Treatment Market report highlights product development and growth strategies such as merger and acquisition adopted by market players along with SWOT Analysis, PEST and Porter’s Five Forces analyses of the Female Sexual Dysfunction Treatment Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.
The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.
The Key Manufacturers covered in this Report:-
- AMAG Pharmaceuticals Inc.
- Duchesnay Inc.
- Emotional Brain BV
- Novo Nordisk AS
- Sprout Pharmaceuticals Inc.
- ...
By Product Type, the market is primarily segmented into:
- Non-hormonal Therapy
- Hormonal Therapy
By Applications, the market is segmented into:
- Sexual Desire Disorders
- Sexual Arousal Disorders
- Orgasm Disorders
- Sexual Pain Disorders
- Post-orgasmic Diseases
- Pelvic Floor Dysfunction
- Other
The Report covers the following Regions:
- North America
- United States
- Canada
- Mexico
- Asia Pacific
- China
- Japan
- South Korea
- India
- Australia
- Indonesia
- Thailand
- Malaysia
- Philippines
- Vietnam
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Central & South America
- Middle East & Africa
- Turkey
- GCC Countries
- Egypt
- South Africa
Objective of the Female Sexual Dysfunction Treatment Market Report:
- To assess the size of the market by value and volume
- Analyze the Female Sexual Dysfunction Treatment Market in terms of regions and major countries
- Highlight recent developments and trends in the market
- Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
- Determine share of the Female Sexual Dysfunction Treatment Market in terms of various segments such as by product type, application, and end-user
- Offer accurate projection of the market for the forecast period using state-of –the-art tools and the current primary and secondary research approaches
- Discuss major factors that impact growth of the Female Sexual Dysfunction Treatment Market
The Female Sexual Dysfunction Treatment Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the Female Sexual Dysfunction Treatment Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders:
- Material suppliers/wholesalers
- Market Distributors/traders
- Regulatory bodies
- Research organizations, and consulting firms
- Commercial research & developments (R&D)
- Trade associations and industry bodies
- Importers and exporters
- End-use industries
Available Customizations:
Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.
Request Discount 
Inquire Before Buy
